EU Committee Backs Pfizer-BMS Anti-Clotting Drug
An advisory committee has recommended that the European Medicines Agency approve an anti-clotting drug for stroke prevention developed by Bristol-Myers Squibb and Pfizer Inc., the companies announced Friday....To view the full article, register now.
Already a subscriber? Click here to view full article